Form 4: Immunovant CFO Sells Shares to Cover Tax Obligations

Eva Renee Barnett, CFO of Immunovant, Inc., sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On July 17, 2024, Eva Renee Barnett, the Chief Financial Officer of Immunovant, Inc., sold 2,939 shares of common stock at a weighted average price of $29.64.
• She also sold 184 shares of common stock at a weighted average price of $30.55.
• These sales were to cover tax withholding obligations related to the vesting of 5,479 restricted stock units (RSUs) on July 12, 2024.
• The sales were mandated by Immunovant's policy requiring tax obligations to be funded by a 'sell to cover' transaction.
• Following these transactions, Barnett beneficially owns 347,544 shares of Immunovant common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a stock sale to cover tax obligations, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This filing indicates that the CFO sold shares to cover tax obligations, which is a common occurrence after RSUs vest.

Stakeholder Impact

• The sale of shares by the CFO could have a minor, temporary impact on the stock price.

Key Dates